Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
phentolamine alpha-1a adrenergic receptor small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Pheochromocytoma[MeSHID:D010673]
Neoplasms[MeSHID:D009369]
Disease Management[MeSHID:D019468]
Necrosis[MeSHID:D009336]
Coronary Artery Vasospasm[MeSHID:D003329]
Left-Sided Heart Failure[MeSHID:D006333]
Diagnosis[MeSHID:D003933]
Drug Overdose[MeSHID:D062787]
Erectile dysfunction[MeSHID:D007172]
Left ventricular structure[MeSHID:D006352]
Infarction[MeSHID:D007238]
Substance Withdrawal Syndrome[MeSHID:D013375]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.23 approved antagonist
phentolamine alpha-1b adrenergic receptor small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Pheochromocytoma[MeSHID:D010673]
Neoplasms[MeSHID:D009369]
Disease Management[MeSHID:D019468]
Necrosis[MeSHID:D009336]
Coronary Artery Vasospasm[MeSHID:D003329]
Left-Sided Heart Failure[MeSHID:D006333]
Diagnosis[MeSHID:D003933]
Drug Overdose[MeSHID:D062787]
Erectile dysfunction[MeSHID:D007172]
Left ventricular structure[MeSHID:D006352]
Infarction[MeSHID:D007238]
Substance Withdrawal Syndrome[MeSHID:D013375]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.13 approved antagonist
phentolamine alpha-1d adrenergic receptor small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Pheochromocytoma[MeSHID:D010673]
Neoplasms[MeSHID:D009369]
Disease Management[MeSHID:D019468]
Necrosis[MeSHID:D009336]
Coronary Artery Vasospasm[MeSHID:D003329]
Left-Sided Heart Failure[MeSHID:D006333]
Diagnosis[MeSHID:D003933]
Drug Overdose[MeSHID:D062787]
Erectile dysfunction[MeSHID:D007172]
Left ventricular structure[MeSHID:D006352]
Infarction[MeSHID:D007238]
Substance Withdrawal Syndrome[MeSHID:D013375]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.31 approved antagonist
phentolamine alpha-2a adrenergic receptor small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Pheochromocytoma[MeSHID:D010673]
Neoplasms[MeSHID:D009369]
Disease Management[MeSHID:D019468]
Necrosis[MeSHID:D009336]
Coronary Artery Vasospasm[MeSHID:D003329]
Left-Sided Heart Failure[MeSHID:D006333]
Diagnosis[MeSHID:D003933]
Drug Overdose[MeSHID:D062787]
Erectile dysfunction[MeSHID:D007172]
Left ventricular structure[MeSHID:D006352]
Infarction[MeSHID:D007238]
Substance Withdrawal Syndrome[MeSHID:D013375]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.74 approved antagonist
phentolamine dopamine d2 receptor NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Pheochromocytoma[MeSHID:D010673]
Neoplasms[MeSHID:D009369]
Disease Management[MeSHID:D019468]
Necrosis[MeSHID:D009336]
Coronary Artery Vasospasm[MeSHID:D003329]
Left-Sided Heart Failure[MeSHID:D006333]
Diagnosis[MeSHID:D003933]
Drug Overdose[MeSHID:D062787]
Erectile dysfunction[MeSHID:D007172]
Left ventricular structure[MeSHID:D006352]
Infarction[MeSHID:D007238]
Substance Withdrawal Syndrome[MeSHID:D013375]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.03 approved unknown
click here to return to the previous page